| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D001104 |
Arbutin |
Arbutin results in decreased expression of LRP6 mRNA | decreases expression | 17103032
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of LRP6 mRNA | decreases expression | 20106945
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LRP6 mRNA | decreases expression | 19150397
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of LRP6 mRNA | increases expression | 12414654
|
| D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LRP6 mRNA | affects cotreatment|affects expression | 17602206
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of LRP6 mRNA | decreases expression | 20106945
|
| D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LRP6 mRNA | affects cotreatment|affects expression | 17602206
|
| D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of LRP6 mRNA | increases expression | 12414654
|
| C011890 |
kojic acid |
kojic acid results in decreased expression of LRP6 mRNA | decreases expression | 16595896
|
| D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of LRP6 mRNA | increases expression | 20069066
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRP6 mRNA | affects binding|increases activity|increases expression | 19710929
|
| C006253 |
pirinixic acid |
pirinixic acid results in increased expression of LRP6 mRNA | increases expression | 18301758
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of LRP6 mRNA | decreases expression | 20106945
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LRP6 mRNA | increases expression | 12377990
|
| D014212 |
Tretinoin |
Tretinoin results in increased expression of LRP6 mRNA | increases expression | 17064353
|
| C025643 |
vinclozolin |
vinclozolin affects the expression of LRP6 mRNA | affects expression | 19015723
|
| D024483 |
Vitamin K 3 |
Vitamin K 3 results in increased expression of LRP6 mRNA | increases expression | 12414654
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 14514962 15322242 11752688 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.15 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.99 | 20127859 20464547 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.68 | 6695378 |
| MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.68 | 10737359 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.59 | 19061943 17162532 19052882 16434500 17620307 18056438 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.59 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.59 | 16835633 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.64 | 15955085 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.66 | 19015723 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.09 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.35 | 16456186 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.44 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.45 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.45 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.45 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.92 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.92 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.92 | 16166294 16443354 16873071 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.64 | 16813970 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.22 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.05 | 19107877 17055752 16540662 19539802 20524982 17978847 20101231 16935385 3581430 18210153 19383236 17761372 18971187 19171122 16328049 17138121 16502159 20514400 21159647 19208518 16779866 16288022 10737359 18393292 19394651 20214788 20432363 17173139 20084675 19919837 18056438 3084413 19418558 19701751 17162532 10672840 16830150 18506893 19519916 19052882 19335982 16569478 19822196 18788625 11831363 16878318 20512989 20727157 17428255 18978308 20007298 16681979 18785209 18665156 16698587 18691550 16807293 18494052 20935162 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.05 | 1917145 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.59 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.59 | 16051514 16096774 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 16120746 18670907 18850075 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.53 | 16936243 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.11 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.26 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.26 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.26 | 17174075 21159647 7505956 2727394 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.64 | 16129372 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.41 | 19052882 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.41 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.83 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.83 | 19176532 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.22 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.80 | 16354765 8697196 15668235 15340226 12621046 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.80 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.75 | 17035595 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
| OMIM:610947 |
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2 |
marker/mechanism |
|
| |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.45 | 15322242 20055451 10048152 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.45 | 10589399 9224671 17551590 8800419 16925845 9664655 9125849 9211117 14991402 9142499 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.38 | 14966744 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.24 | 20387270 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.24 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.75 | 19107877 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.75 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.63 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.63 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.16 | 16714409 15322242 18230668 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.16 | 18230668 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.12 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 10568697 9294722 |
| MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.18 | 16302075 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.37 | 20426865 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.37 | 16530937 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.90 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.90 | 16938888 9664655 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.22 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
13.22 | 21071580 20387270 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.22 | 19236843 20131406 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.98 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.98 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.98 | 17994277 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.98 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.36 | 16417039 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.02 | 17312396 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.20 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.22 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.17 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.17 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.17 | 9664655 14991402 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.40 | 19772884 19176532 16221962 18467677 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.40 | 16120746 12621046 15340226 |
| MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
13.24 | 19797860 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
13.24 | 16354765 15340226 8697196 18606429 16959395 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.23 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.61 | 16778211 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.06 | 16467254 |
| MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
4.94 | 18785209 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.94 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.65 | 16306350 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.81 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.03 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.03 | 15992940 17551590 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.35 | 8314463 10903974 18776723 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.30 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.76 | 12371664 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
2.78 | 17143497 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.73 | 16482212 16932348 19285840 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 19850784 17596541 16294345 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.17 | 19642359 17339181 16766008 17712046 19225113 17107899 19035177 16891316 16140955 17361223 16331271 16823087 17301526 12679006 16935935 9834237 17217047 17294898 17368321 16788101 15748426 17649720 19029980 19075265 17506722 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.78 | 16417039 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.33 | 9224671 |
| MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.84 | 20032147 19638242 18665156 18522880 18407596 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.41 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.41 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.41 | 16248980 18397230 |
| MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.11 | 17034775 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.35 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
14.35 | 17602206 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
14.35 | 12112319 19256749 19254457 19073162 19812893 10737359 18977376 21071580 18754104 2422723 20452335 19294768 19690152 2862719 18644402 15885732 20137499 21047994 20101389 20434301 19638242 21167192 19499222 19551842 15175105 19833225 18648771 20492335 21278145 18978307 19426721 20118626 12771043 20405173 20501860 9163691 19642983 19996281 19090486 19850985 20583210 19427195 19255062 16942905 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.35 | 20007298 15890375 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.35 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
9.99 | 3124819 18079962 21159647 18544905 18164116 18093689 19519916 18775883 9362446 19009564 17174075 19539802 18282651 16267830 19126423 17854601 18308698 2563599 17942915 16842330 19004024 18253720 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
9.99 | 18544905 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.99 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.36 | 20135361 18816296 20064080 20464547 6695378 18569708 18520028 17053015 20869020 |
| MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.36 | 20970405 21163286 20512841 6695378 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.36 | 19555203 11884234 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.79 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
3.78 | 16752155 |
| MESH:D008545 |
Melanoma |
|
Vitamin K 3 |
3.78 | 19082730 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.47 | 16940565 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.09 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.15 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.58 | 9029167 3581430 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.27 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.27 | 17405874 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.27 | 16594593 16946489 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 18481113 19348381 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.63 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.63 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.07 | 9142499 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.36 | 20387270 |
| MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.18 | 20387270 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.35 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
2.92 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.28 | 16540662 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.28 | 15976015 |
| MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
4.13 | 12065085 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
| MESH:D011141 |
Polyuria |
|
Lithium Chloride |
6.05 | 19692487 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.03 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.03 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.66 | 11896295 11118676 11222880 11399792 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.66 | 18042343 18220299 19015723 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.98 | 18220299 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.97 | 17292933 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.98 | 18629315 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.64 | 16636307 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.84 | 16723453 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.13 | 16283617 16116481 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
18.06 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
18.06 | 12065085 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
18.06 | 8532709 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
18.06 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
18.06 | 16467112 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.34 | 20155912 2093021 |
| MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.34 | 18456281 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.34 | 17261132 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.24 | 7505956 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.24 | 17045167 16026305 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.81 | 16051514 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.24 | 16040207 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.19 | 17053015 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.70 | 16129372 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.67 | 16752155 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.09 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.99 | 16287080 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |